Vortioxetine hemihydrobromide

N/A

Report date: 2025/06/10 17:54:58

Base Information

Drug NameVortioxetine hemihydrobromide
Drug Alias NameSF001SF-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 1b (5-HT1b) receptor agonistsSerotonin 1d (5-HT1d) receptor antagonists +[6] 
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptor +[6] 
Therapy Area/IndicationsDepressive DisorderHIV InfectionsMeningitis, Cryptococcal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUgandaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSeasons Biotechnology (Taizhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaSeasons Biotechnology (Taizhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive DisorderHIV InfectionsMeningitis, Cryptococcal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A